RecruitingNot Applicable

Efficacy and Sustainability of a Carepartner-Integrated Telerehabilitation Program for Persons With Stroke

United States220 participantsStarted 2025-03-25

Plain-language summary

Stroke is a leading cause of long-term disability. Research has placed little emphasis on integrating care partners (CP) (family members) into the rehabilitation process without increasing negative care partner outcomes. The research team has developed and implemented a novel, web-based care partner-focused intervention (CARE-CITE) designed to foster problem-solving and skill building while facilitating care partner engagement during stroke survivor (SS) upper extremity practice of daily activities in the home setting. By providing a family-focused approach to rehabilitation interventions, this project will help develop more effective treatments that improve CP and outcomes after stroke.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

CarePartners (CP): Inclusion Criteria: * Must be at least18 years old, * Able to read and write English, * Mini-mental test score greater than 24 * Individuals who are a spouse/partner or family member dwelling in the same household and self-identify as the primary caregiver of the SS. Stroke Survivors (SS): Inclusion Criteria: * Must be at least18 years old * More than 3 months and less than 2yrs post-ischemic or hemorrhagic event * Discharged home from the hospital with minimal to moderate UE deficits (can actively initiate 20 degrees of wrist and 10 degrees of finger extension) * Mini-mental test greater than 24 * No physician determined medical problems that would limit participation, * Must have CP living in the home Exclusion Criteria for CP and SS: * Significant cognitive deficits

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

SS's Upper Extremity Functional Capacity

Timeframe: Baseline, 2 months and 6 months post-intervention

SS's UE activity performance using the Motor Activity Log (MAL)

Timeframe: Baseline, 2 months and 6 months post-intervention

SS's Social Participation Score using the Stroke Impact Scale (SIS) score

Timeframe: Baseline, 2 months and 6 months post-intervention

CP Quality of Life

Timeframe: Baseline, 2 months and 6 months post-intervention

CP Strain using the Caregiver Strain Index(CSI)

Timeframe: Baseline, 2 months and 6 months post-intervention

Trial details

NCT IDNCT06655402

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-02

Contact for this trial

Sarah R Blanton, PT, DPT

(404) 712-2222 sblanto@emory.edu

View on ClinicalTrials.gov More Stroke trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

SS's Upper Extremity Functional Capacity

Timeframe: Baseline, 2 months and 6 months post-intervention

SS's UE activity performance using the Motor Activity Log (MAL)

Timeframe: Baseline, 2 months and 6 months post-intervention

SS's Social Participation Score using the Stroke Impact Scale (SIS) score

Timeframe: Baseline, 2 months and 6 months post-intervention

CP Quality of Life

Timeframe: Baseline, 2 months and 6 months post-intervention

CP Strain using the Caregiver Strain Index(CSI)

Timeframe: Baseline, 2 months and 6 months post-intervention